logo

For the Inventor, By the Inventor

Chungcheongnam-do, South Korea

Jin Soo Shin

This inventor holds 6 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignees: Katholieke Universiteit Leuven, Korea Research Institute of Chemical Technology, Novartis Ag. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Soo Shin. Retrieved from https://idiyas.com/inventor/jin-soo-shin-uk1ct8b4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Chungcheongnam-do, KR (2016 - 2018)
  • Daejeon, KR (2024)

Company Filing History:

goldMedal6 out of 631 
 
Katholieke Universiteit Leuven
 patents
silverMedal6 out of 655 
 
Korea Research Institute of Chemical Technology
 patents
bronzeMedal2 out of 3,978 
 
Novartis Ag
 patents
where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 12286423 - Antiviral 1,3-di-oxo-indene compounds (2025-04-29),
2. 12083092 - Antiviral 1,3-di-oxo-indene compounds (2024-09-10),
3. 9951058 - Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (2018-04-24),
4. 9890133 - Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (2018-02-13),
5. 9790197 - Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (2017-10-17),
6. 9464067 - Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (2016-10-11),

Title: Innovations of Jin Soo Shin

Introduction

Jin Soo Shin is a prominent inventor based in Chungcheongnam-do, South Korea. He has made significant contributions to the field of chemical technology, particularly in the development of antiviral compounds. With a total of six patents to his name, his work has garnered attention in both academic and industrial circles.

Latest Patents

One of Jin Soo Shin's latest patents includes the invention of antiviral 1,3-di-oxo-indene compounds. This invention provides compounds of Formula (I), which are designed to combat viral infections. The innovative nature of these compounds highlights his commitment to advancing medical science and public health.

Career Highlights

Throughout his career, Jin Soo Shin has worked with esteemed institutions such as the Korea Research Institute of Chemical Technology and Katholieke Universiteit Leuven. His experience in these organizations has allowed him to refine his research skills and contribute to groundbreaking projects in chemical technology.

Collaborations

Jin Soo Shin has collaborated with notable colleagues, including Hae Soo Kim and Soo Bong Han. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Jin Soo Shin's contributions to the field of antiviral compounds and his collaborations with leading institutions and colleagues underscore his impact as an inventor. His work continues to inspire advancements in chemical technology and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…